カテゴリー： GlobalInfoResearch, 世界

がんサポーティブケア薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）

【英語タイトル】Global Cancer Supportive Care Drugs Market 2019 by Company, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが出版した調査資料（GIR9100313）・商品コード：GIR9100313
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2019年10月11日（※2024年版があります。お問い合わせください）
・ページ数：101
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥515,040見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）USD5,220 ⇒換算￥772,560見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,030,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
本調査レポートは、がんサポーティブケア薬の世界市場について調べ、まとめました。種類別セグメントは、G-CSF（顆粒球コロニー刺激因子）、ESA（赤血球生成刺激剤）、制吐薬、ビスホスホネート、オピオイド、NSAID等、用途別セグメントは、化学療法療法、放射線療法等に区分しました。がんサポーティブケア薬の世界市場概観、企業動向、企業別がんサポーティブケア薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・がんサポーティブケア薬の市場概観
・がんサポーティブケア薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・がんサポーティブケア薬の企業別販売動向、市場シェア、市場集中度、競争動向
・がんサポーティブケア薬の世界市場規模
・がんサポーティブケア薬の北米市場分析（アメリカ、カナダ、メキシコ等）
・がんサポーティブケア薬のアメリカ市場規模推移
・がんサポーティブケア薬のカナダ市場規模推移
・がんサポーティブケア薬のメキシコ市場規模推移
・がんサポーティブケア薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・がんサポーティブケア薬のドイツ市場規模推移
・がんサポーティブケア薬のイギリス市場規模推移
・がんサポーティブケア薬のロシア市場規模推移
・がんサポーティブケア薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・がんサポーティブケア薬の日本市場規模推移
・がんサポーティブケア薬の中国市場規模推移
・がんサポーティブケア薬の韓国市場規模推移
・がんサポーティブケア薬のインド市場規模推移
・がんサポーティブケア薬の東南アジア市場規模推移
・がんサポーティブケア薬の南米市場分析（ブラジル、アルゼンチン等）
・がんサポーティブケア薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・がんサポーティブケア薬の種類別分析/販売量、売上、市場シェア（G-CSF（顆粒球コロニー刺激因子）、ESA（赤血球生成刺激剤）、制吐薬、ビスホスホネート、オピオイド、NSAID）
・がんサポーティブケア薬の用途別分析/市場規模（化学療法療法、放射線療法）
・がんサポーティブケア薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・がんサポーティブケア薬の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Scope of the Report:
The global Cancer Supportive Care Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Cancer Supportive Care Drugs.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Cancer Supportive Care Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Cancer Supportive Care Drugs market by product type and applications/end industries.

Market Segment by Companies, this report covers
Tesaro
Roche
Johnson & Johnson
Amgen
Merck
Heron Pharma
Helsinn Healthcare

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
G-CSFs (Granulocyte-colony Stimulating Factors)
ESAs (Erythropoiesis Stimulating Agents)
Anti-emetics
Bisphosphonates
Opioids
NSAIDs

Market Segment by Applications, can be divided into
Chemotherapy Therapy
Radiation Therapy

【レポートの目次】

Table of Contents

1 Cancer Supportive Care Drugs Market Overview
1.1 Product Overview and Scope of Cancer Supportive Care Drugs
1.2 Classification of Cancer Supportive Care Drugs by Types
1.2.1 Global Cancer Supportive Care Drugs Revenue Comparison by Types (2019-2024)
1.2.2 Global Cancer Supportive Care Drugs Revenue Market Share by Types in 2018
1.2.3 G-CSFs (Granulocyte-colony Stimulating Factors)
1.2.4 ESAs (Erythropoiesis Stimulating Agents)
1.2.5 Anti-emetics
1.2.6 Bisphosphonates
1.2.7 Opioids
1.2.8 NSAIDs
1.3 Global Cancer Supportive Care Drugs Market by Application
1.3.1 Global Cancer Supportive Care Drugs Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Chemotherapy Therapy
1.3.3 Radiation Therapy
1.4 Global Cancer Supportive Care Drugs Market by Regions
1.4.1 Global Cancer Supportive Care Drugs Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Cancer Supportive Care Drugs Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Cancer Supportive Care Drugs Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cancer Supportive Care Drugs Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Cancer Supportive Care Drugs Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cancer Supportive Care Drugs Status and Prospect (2014-2024)
1.5 Global Market Size of Cancer Supportive Care Drugs (2014-2024)
2 Company Profiles
2.1 Tesaro
2.1.1 Business Overview
2.1.2 Cancer Supportive Care Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Tesaro Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.2 Roche
2.2.1 Business Overview
2.2.2 Cancer Supportive Care Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Roche Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.3 Johnson & Johnson
2.3.1 Business Overview
2.3.2 Cancer Supportive Care Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Johnson & Johnson Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.4 Amgen
2.4.1 Business Overview
2.4.2 Cancer Supportive Care Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Amgen Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.5 Merck
2.5.1 Business Overview
2.5.2 Cancer Supportive Care Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Merck Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.6 Heron Pharma
2.6.1 Business Overview
2.6.2 Cancer Supportive Care Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Heron Pharma Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.7 Helsinn Healthcare
2.7.1 Business Overview
2.7.2 Cancer Supportive Care Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Helsinn Healthcare Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2017-2018)
3 Global Cancer Supportive Care Drugs Market Competition, by Players
3.1 Global Cancer Supportive Care Drugs Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Cancer Supportive Care Drugs Players Market Share
3.2.2 Top 10 Cancer Supportive Care Drugs Players Market Share
3.3 Market Competition Trend
4 Global Cancer Supportive Care Drugs Market Size by Regions
4.1 Global Cancer Supportive Care Drugs Revenue and Market Share by Regions
4.2 North America Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
4.3 Europe Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
4.5 South America Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
5 North America Cancer Supportive Care Drugs Revenue by Countries
5.1 North America Cancer Supportive Care Drugs Revenue by Countries (2014-2019)
5.2 USA Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
5.3 Canada Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
5.4 Mexico Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
6 Europe Cancer Supportive Care Drugs Revenue by Countries
6.1 Europe Cancer Supportive Care Drugs Revenue by Countries (2014-2019)
6.2 Germany Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
6.3 UK Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
6.4 France Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
6.5 Russia Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
6.6 Italy Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Cancer Supportive Care Drugs Revenue by Countries
7.1 Asia-Pacific Cancer Supportive Care Drugs Revenue by Countries (2014-2019)
7.2 China Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
7.3 Japan Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
7.4 Korea Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
7.5 India Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
8 South America Cancer Supportive Care Drugs Revenue by Countries
8.1 South America Cancer Supportive Care Drugs Revenue by Countries (2014-2019)
8.2 Brazil Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
8.3 Argentina Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
8.4 Colombia Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Cancer Supportive Care Drugs by Countries
9.1 Middle East and Africa Cancer Supportive Care Drugs Revenue by Countries (2014-2019)
9.2 Saudi Arabia Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
9.3 UAE Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
9.4 Egypt Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
9.5 Nigeria Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
9.6 South Africa Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
10 Global Cancer Supportive Care Drugs Market Segment by Type
10.1 Global Cancer Supportive Care Drugs Revenue and Market Share by Type (2014-2019)
10.2 Global Cancer Supportive Care Drugs Market Forecast by Type (2019-2024)
10.3 G-CSFs (Granulocyte-colony Stimulating Factors) Revenue Growth Rate (2014-2024)
10.4 ESAs (Erythropoiesis Stimulating Agents) Revenue Growth Rate (2014-2024)
10.5 Anti-emetics Revenue Growth Rate (2014-2024)
10.6 Bisphosphonates Revenue Growth Rate (2014-2024)
10.7 Opioids Revenue Growth Rate (2014-2024)
10.8 NSAIDs Revenue Growth Rate (2014-2024)
11 Global Cancer Supportive Care Drugs Market Segment by Application
11.1 Global Cancer Supportive Care Drugs Revenue Market Share by Application (2014-2019)
11.2 Cancer Supportive Care Drugs Market Forecast by Application (2019-2024)
11.3 Chemotherapy Therapy Revenue Growth (2014-2019)
11.4 Radiation Therapy Revenue Growth (2014-2019)
12 Global Cancer Supportive Care Drugs Market Size Forecast (2019-2024)
12.1 Global Cancer Supportive Care Drugs Market Size Forecast (2019-2024)
12.2 Global Cancer Supportive Care Drugs Market Forecast by Regions (2019-2024)
12.3 North America Cancer Supportive Care Drugs Revenue Market Forecast (2019-2024)
12.4 Europe Cancer Supportive Care Drugs Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Cancer Supportive Care Drugs Revenue Market Forecast (2019-2024)
12.6 South America Cancer Supportive Care Drugs Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Cancer Supportive Care Drugs Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Cancer Supportive Care Drugs Picture
Table Product Specifications of Cancer Supportive Care Drugs
Table Global Cancer Supportive Care Drugs and Revenue (Million USD) Market Split by Product Type
Figure Global Cancer Supportive Care Drugs Revenue Market Share by Types in 2018
Figure G-CSFs (Granulocyte-colony Stimulating Factors) Picture
Figure ESAs (Erythropoiesis Stimulating Agents) Picture
Figure Anti-emetics Picture
Figure Bisphosphonates Picture
Figure Opioids Picture
Figure NSAIDs Picture
Table Global Cancer Supportive Care Drugs Revenue (Million USD) by Application (2014-2024)
Figure Cancer Supportive Care Drugs Revenue Market Share by Applications in 2018
Figure Chemotherapy Therapy Picture
Figure Radiation Therapy Picture
Table Global Market Cancer Supportive Care Drugs Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Cancer Supportive Care Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Cancer Supportive Care Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Cancer Supportive Care Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Cancer Supportive Care Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Cancer Supportive Care Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Cancer Supportive Care Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Table Tesaro Basic Information, Manufacturing Base and Competitors
Table Tesaro Cancer Supportive Care Drugs Type and Applications
Table Tesaro Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Cancer Supportive Care Drugs Type and Applications
Table Roche Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Cancer Supportive Care Drugs Type and Applications
Table Johnson & Johnson Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Cancer Supportive Care Drugs Type and Applications
Table Amgen Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Cancer Supportive Care Drugs Type and Applications
Table Merck Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Heron Pharma Basic Information, Manufacturing Base and Competitors
Table Heron Pharma Cancer Supportive Care Drugs Type and Applications
Table Heron Pharma Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Helsinn Healthcare Basic Information, Manufacturing Base and Competitors
Table Helsinn Healthcare Cancer Supportive Care Drugs Type and Applications
Table Helsinn Healthcare Cancer Supportive Care Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Global Cancer Supportive Care Drugs Revenue (Million USD) by Players (2014-2019)
Table Global Cancer Supportive Care Drugs Revenue Share by Players (2014-2019)
Figure Global Cancer Supportive Care Drugs Revenue Share by Players in 2017
Figure Global Cancer Supportive Care Drugs Revenue Share by Players in 2018
Figure Global Top 5 Players Cancer Supportive Care Drugs Revenue Market Share in 2018
Figure Global Top 10 Players Cancer Supportive Care Drugs Revenue Market Share in 2018
Figure Global Cancer Supportive Care Drugs Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Cancer Supportive Care Drugs Revenue (Million USD) by Regions (2014-2019)
Table Global Cancer Supportive Care Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Cancer Supportive Care Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Cancer Supportive Care Drugs Revenue Market Share by Regions in 2018
Figure North America Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Figure Europe Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Figure South America Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Table North America Cancer Supportive Care Drugs Revenue by Countries (2014-2019)
Table North America Cancer Supportive Care Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Cancer Supportive Care Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Cancer Supportive Care Drugs Revenue Market Share by Countries in 2018
Figure USA Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Figure Canada Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Figure Mexico Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Table Europe Cancer Supportive Care Drugs Revenue (Million USD) by Countries (2014-2019)
Figure Europe Cancer Supportive Care Drugs Revenue Market Share by Countries (2014-2019)
Figure Europe Cancer Supportive Care Drugs Revenue Market Share by Countries in 2018
Figure Germany Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Figure UK Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Figure France Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Figure Russia Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Figure Italy Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Cancer Supportive Care Drugs Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Cancer Supportive Care Drugs Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Cancer Supportive Care Drugs Revenue Market Share by Countries in 2018
Figure China Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Figure Japan Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Figure Korea Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Figure India Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Table South America Cancer Supportive Care Drugs Revenue by Countries (2014-2019)
Table South America Cancer Supportive Care Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Cancer Supportive Care Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Cancer Supportive Care Drugs Revenue Market Share by Countries in 2018
Figure Brazil Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Figure Argentina Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Figure Colombia Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Cancer Supportive Care Drugs Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Cancer Supportive Care Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Cancer Supportive Care Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Cancer Supportive Care Drugs Revenue Market Share by Countries in 2018
Figure Saudi Arabia Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Figure UAE Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Figure Egypt Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Figure Nigeria Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Figure South Africa Cancer Supportive Care Drugs Revenue and Growth Rate (2014-2019)
Table Global Cancer Supportive Care Drugs Revenue (Million USD) by Type (2014-2019)
Table Global Cancer Supportive Care Drugs Revenue Share by Type (2014-2019)
Figure Global Cancer Supportive Care Drugs Revenue Share by Type (2014-2019)
Figure Global Cancer Supportive Care Drugs Revenue Share by Type in 2018
Table Global Cancer Supportive Care Drugs Revenue Forecast by Type (2019-2024)
Figure Global Cancer Supportive Care Drugs Market Share Forecast by Type (2019-2024)
Figure Global G-CSFs (Granulocyte-colony Stimulating Factors) Revenue Growth Rate (2014-2019)
Figure Global ESAs (Erythropoiesis Stimulating Agents) Revenue Growth Rate (2014-2019)
Figure Global Anti-emetics Revenue Growth Rate (2014-2019)
Figure Global Bisphosphonates Revenue Growth Rate (2014-2019)
Figure Global Opioids Revenue Growth Rate (2014-2019)
Figure Global NSAIDs Revenue Growth Rate (2014-2019)
Table Global Cancer Supportive Care Drugs Revenue by Application (2014-2019)
Table Global Cancer Supportive Care Drugs Revenue Share by Application (2014-2019)
Figure Global Cancer Supportive Care Drugs Revenue Share by Application (2014-2019)
Figure Global Cancer Supportive Care Drugs Revenue Share by Application in 2018
Table Global Cancer Supportive Care Drugs Revenue Forecast by Application (2019-2024)
Figure Global Cancer Supportive Care Drugs Market Share Forecast by Application (2019-2024)
Figure Global Chemotherapy Therapy Revenue Growth Rate (2014-2019)
Figure Global Radiation Therapy Revenue Growth Rate (2014-2019)
Figure Global Cancer Supportive Care Drugs Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Cancer Supportive Care Drugs Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Cancer Supportive Care Drugs Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Cancer Supportive Care Drugs Revenue Market Forecast (2019-2024)
Figure Europe Cancer Supportive Care Drugs Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Cancer Supportive Care Drugs Revenue Market Forecast (2019-2024)
Figure South America Cancer Supportive Care Drugs Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Cancer Supportive Care Drugs Revenue Market Forecast (2019-2024)


【掲載企業】

Tesaro、 Roche、 Johnson & Johnson、 Amgen、 Merck、 Heron Pharma、 Helsinn Healthcare

★調査レポート[がんサポーティブケア薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）] (コード：GIR9100313)販売に関する免責事項を必ずご確認ください。
★調査レポート[がんサポーティブケア薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 腫瘍学小分子薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9100188 / GlobalInfoResearch / 2019年10月10日 / 本調査レポートは、腫瘍学小分子薬の世界市場について調べ、まとめました。種類別セグメントは、化学療法薬、免疫調節薬、標的療法薬、ホルモン療法、その他等、用途別セグメントは、血液がん、乳がん、胃腸がん、前立腺がん、肺がん、その他等に区分しました。腫瘍学小分子薬の世界市場概観、企業動向、企業別腫瘍学小分子薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・腫瘍学小分子薬の市場概観 ・腫瘍学小分子薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・腫瘍学小分子薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・腫瘍学小分子薬の世界市場規模 ・腫瘍学小分子薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・腫瘍学小分子薬のアメリカ市場規模推移 ・腫瘍学小分子薬のカナダ市場規模推移 ・腫瘍学小分子薬のメキシコ市場規模推移 ・腫瘍学小分子薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）... Scope of the Report: The global Oncology Small Molecule Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Oncology Small Molecule Drugs. Europe also play important...
  • 膠芽腫治療薬の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9100019 / GlobalInfoResearch / 2019年10月9日 / 本調査レポートは、膠芽腫治療薬の世界市場について調べ、まとめました。種類別セグメントは、VEGF / VEGFR阻害剤、アルキル化剤、その他の抗腫瘍薬等、用途別セグメントは、病院、がん研究機構、長期介護センター、診断センター等に区分しました。膠芽腫治療薬の世界市場概観、メーカー動向、メーカー別膠芽腫治療薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・膠芽腫治療薬の市場概観 ・膠芽腫治療薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・膠芽腫治療薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・膠芽腫治療薬の世界市場規模 ・膠芽腫治療薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・膠芽腫治療薬のアメリカ市場規模推移 ・膠芽腫治療薬のカナダ市場規模推移... Scope of the Report: The worldwide market for Glioblastoma Treatment Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Glioblastoma Treatment Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers Sigma-Tau Pharmaceuticals F. Hoffmann-La Roche AG Bristol-Myers Squibb...

    • ◆H&Iグローバルリサーチのお客様（例）◆